A better understanding of the mechanisms by which SFN induces cell cycle arrest and apoptosis is crucial for its future development as a clinically valuable cancer preventive/therapeutic agent, and this information could contribute to the identification of mechanism-based biomarkers crucially involved in future clinical trials. The gene discussed is SFN; the disease is cancer.